CHORD - CHOlesterol Lowering and Residual Risk in Type 2 Diabetes

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Type 2 Diabetes
  • Age: Between 18 - 89 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    Group 1: Type 2 Diabetic Participants
    1. Age = 18 & < 90
    2. Participants diagnosed with Type 2 diabetes
    3. Participants with LDL-C >100mg/dl
    4. Participants able and willing to provide written informed consent for the study
    Group 2:Controls without known diabetes
    1. Age = 18 & < 90
    2. Participants with LDL-C >100mg/dl, or Lp(a)>50 mg/dl
    3. Participants able and willing to provide written informed consent for the study

You may not be eligible for this study if the following are true:

  • Group 1: Type 2 Diabetic Participants
    1. Those who have cardiovascular disease
    2. Participants with blood test results within certain ranges as listed in the protocol
    3. Use of a PCSK9 inhibitor
    4. Use of maximal intensity statin (cholesterol-lowering drugs)
    5. Participants with infection in the past 30 days
    6. Those who had any hospitalization in the past 30 days
    7. Use of Immunosuppressive therapy
    8. Use of any antithrombotic therapy
    9. Use of aspirin
    10. Use of NSAID within the past 72 hours
    11. Participants who are pregnant
    12. Participants with anemia
    13. A history of severe bleeding or bleeding disorders
    14. Those with chronic kidney disease (stages 4 and 5)
    Group 2: Controls without diabetes
    1. Participants with Diabetes (type 1 or type 2)
    2. All other exclusions are identical to the type 2 diabetes group.



If you are registered as a volunteer, please login to the dashboard to send referrals.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.